Valuation: Bayer AG

Market Cap 52.34B 59.88B 48.1B 44.84B 85.05B 5,701B 86.34B 577B 224B 2,802B 225B 220B 9,657B P/E 2026 *
23x
P/E 2027 * 17.3x
Enterprise Value 84.07B 96.16B 77.26B 72.01B 137B 9,156B 139B 927B 361B 4,501B 361B 353B 15,509B EV / Sales 2026 *
1.85x
EV / Sales 2027 * 1.73x
Free-Float
100%
Yield 2026 *
0.43%
Yield 2027 * 1.18%
1 day-0.26%
1 week+13.53%
Current month+10.23%
1 month+56.48%
3 months+34.42%
6 months+40.42%
Current year+44.18%
1 week 45.41
Extreme 45.41
53.92
1 month 34.52
Extreme 34.52
53.92
Current year 32.96
Extreme 32.96
53.92
1 year 24.8
Extreme 24.805
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 66 2022-03-31
Director/Board Member 60 2017-03-31
Date Insider Type Main position Quantity % Market Cap.
Mar. 17Buy

Director

1,530 0.0002%
Mar. 17Buy

Executive/Senior Manager

13,000 0.0013%
Mar. 17Buy

Chairman

2,671 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+13.53%+102.47%+5.31% 59.99B
+1.86%+7.65%+55.77%+158.84% 1,082B
+3.57%+7.42%+69.09%+58.92% 633B
+3.99%+7.37%+36.87%+93.77% 461B
-0.35%+1.85%+31.30%+24.86% 339B
-0.56%+2.80%+39.13%+28.20% 301B
-0.08%+1.52%+29.96%+42.13% 292B
-1.54%+3.56%-25.96%-40.53% 225B
+3.55%+6.05%+26.04%+68.52% 202B
+4.21%+6.00%+17.72%+70.33% 163B
Average +0.95%+5.78%+38.24%+51.04% 375.97B
Weighted average by Cap. +1.02%+5.67%+42.75%+79.32%

Financials

2026 *2027 *
Net sales 45.55B 52.11B 41.86B 39.02B 74.01B 4,961B 75.13B 503B 195B 2,439B 196B 191B 8,404B 46.7B 53.42B 42.92B 40.01B 75.88B 5,087B 77.03B 515B 200B 2,500B 201B 196B 8,616B
Net income 2.13B 2.44B 1.96B 1.83B 3.47B 232B 3.52B 23.54B 9.15B 114B 9.16B 8.96B 394B 2.93B 3.35B 2.69B 2.51B 4.76B 319B 4.83B 32.29B 12.55B 157B 12.57B 12.3B 540B
Net Debt 31.72B 36.29B 29.15B 27.17B 51.54B 3,455B 52.32B 350B 136B 1,698B 136B 133B 5,853B 28.52B 32.62B 26.21B 24.43B 46.33B 3,106B 47.03B 315B 122B 1,527B 122B 120B 5,261B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
26-07-03 53.36 0.00% 4,165,468
26-07-02 €53.36 +8.90% 7,953,614
26-07-01 €49.00 +1.22% 4,782,948
26-06-30 €48.41 +5.17% 5,438,551
26-06-29 €46.03 -2.06% 4,205,722
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
53.36EUR
Average target price
52.47EUR
Spread / Average Target
-1.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock